NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter C. FarrellDirector2025-11-147,314$244.46
$1.79MSell
Peter C. FarrellDirector2025-11-1411,442$101.64
$1.16MBuy
Peter C. FarrellDirector2025-11-122,000$252.05
$504.10kSell
Michael J. FarrellChairman and CEO2025-11-112,231$250.10
$557.97kSell
Michael J. FarrellChairman and CEO2025-11-113,459$250.10
$865.10kSell
Witte Jan DeDirector2025-11-11487$250.25
$121.87kSell
Harjit GillDirector2025-11-1138$250.10
$9.50kSell
Michael J. RiderGlobal General Counsel2025-11-11135$250.10
$33.76kSell
Michael J. RiderGlobal General Counsel2025-11-11173$250.10
$43.27kSell
Peter C. FarrellDirector2025-11-11162$250.10
$40.52kSell

1 of 9

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc13.04%19,040,440$4.64BInstitution
Blackrock Inc8.41%12,277,966$2.99BInstitution
State Street Corp4.49%6,549,164$1.60BInstitution
Bank Of New York Mellon Corp3.12%4,552,916$1.11BInstitution
Geode Capital Management LLC2.91%4,251,688$1.04BInstitution
Morgan Stanley1.58%2,313,138$564.22MInstitution
Invesco Ltd1.44%2,108,763$514.37MInstitution
Christopher G. Roberts1.16%1,700,337$414.75MInsider
Northern Trust Corp1.16%1,697,882$414.15MInstitution
Michael A. 1. Quinn0.88%1,277,650$311.64MInsider

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD62.54%4.26%Net SellingNet Selling
ALC47.59%0.00%
WST95.51%3.76%Net Buying
BDX89.83%0.66%Net SellingNet Selling
HOLX86.01%13.99%Net SellingNet Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 62.54% institutional shareholders, 4.26% Resmed insiders, and 33.20% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $426.36M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.